Pathstone Holdings’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Pathstone Holdings’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$265K	Buy	+3,676	New	+$955K	﹤0.01%	2190

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

Berger Financial Group Plymouth, Minnesota $2.01B AUM 15.82% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

Pathstone Holdings's FBT Position: Q3 2026 in Review

Pathstone Holdings opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026: 3,676 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #2190 among its holdings.

311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Pathstone Holdings held 3,676 shares of First Trust NYSE Arca Biotechnology Index Fund worth $265K as of Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Pathstone Holdings position in Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Pathstone Holdings's portfolio in Q3 2026, its #2190 holding.
311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Pathstone Holdings's 13F filing for Q3 2026, filed 13 Nov 2026.